SEARCH

SEARCH BY CITATION

References

  • 1
    Henrickson KJ. Parainfluenza viruses. Clin Microbiol Rev 2003; 16:242264.
  • 2
    Collins PL, Chanock RM, McIntosh K. Parainfluenza viruses; in Fields BN, Knipe DM, Howley PM (eds): Fields Virology, 3rd edn. Philadelphia: Lippincott-raven, 1996; 12051241.
  • 3
    Marx A, Gary HE Jr, Marston BJ, et al. Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection. Clin Infect Dis 1999; 29:134140.
  • 4
    Denny FW, Clyde WA Jr. Acute lower respiratory tract infections in nonhospitalized children. J Pediatr 1986; 108(5 Pt 1):635646.
  • 5
    Reed G, Jewett PH, Thompson J, Tollefson S, Wright PF. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old. J Infect Dis 1997; 175:807813.
  • 6
    Glezen WP, Frank AL, Taber LH, Kasel JA. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis 1984; 150:851857.
  • 7
    Sydnor ER, Greer A, Budd AP et al. An outbreak of human parainfluenza virus 3 infection in an outpatient hematopoietic stem cell transplantation clinic. Am J Infect Control 2012; 40:601605.
  • 8
    Chemaly RF, Hanmod SS, Rathod DB et al. The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation. Blood 2012; 119:27382745. quiz 969.
  • 9
    Berman S. Epidemiology of acute respiratory infections in children of developing countries. Rev Infect Dis 1991; 13(Suppl 6):S454S462.
  • 10
    Iñiguez OF, Vega-Briseño LE, Pulgar BD, Díaz PC, Sánchez DI. Laringotraqueobrinquitis en niños hospitalizados: características clínicas. Rev Chil Pediatr 2005; 76:357362.
  • 11
    de Arruda E, Hayden FG, McAuliffe JF et al. Acute respiratory viral infections in ambulatory children of urban northeast Brazil. J Infect Dis 1991; 164:252258.
  • 12
    Carballal G, Videla CM, Espinosa MA et al. Multicentered study of viral acute lower respiratory infections in children from four cities of Argentina, 1993-1994. J Med Virol 2001; 64:167174.
  • 13
    Fe MM, Monteiro AJ, Moura FE. Parainfluenza virus infections in a tropical city: clinical and epidemiological aspects. Braz J Infect Dis 2008; 12:192197.
  • 14
    Herrera D, de la Hoz F, Velandia M. Severe respiratory disease and its relationship with respiratory viruses in Colombia. Int J Infect Dis 2008; 12:139142.
  • 15
    Noyola DE, Arteaga-Dominguez G. Contribution of respiratory syncytial virus, influenza and parainfluenza viruses to acute respiratory infections in San Luis Potosi, Mexico. Pediatr Infect Dis J 2005; 24:10491052.
  • 16
    Garcia J, Sovero M, Torres AL et al. Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers. Influenza Other Respir Viruses 2009; 3:6974.
  • 17
    Laguna-Torres VA, Gomez J, Ocana V et al. Influenza-like illness sentinel surveillance in Peru. PLoS ONE 2009; 4:e6118.
  • 18
    Comach G, Teneza-Mora N, Kochel TJ et al. Sentinel surveillance of influenza-like illness in two hospitals in Maracay, Venezuela: 2006-2010. PLoS ONE 2012; 7:e44511.
  • 19
    WHO. WHO Recommended Surveillance Standards: WHO; 1999. Available at: http://www.who.int/csr/resources/publications/surveillance/whocdscsrisr992.pdf (Accessed 15 October 2012).
  • 20
    Caceda ER, Kochel TJ. Application of modified shell vial culture procedure for arbovirus detection. PLoS ONE 2007; 2:e1034.
  • 21
    Echevarria JE, Erdman DD, Swierkosz EM, Holloway BP, Anderson LJ. Simultaneous detection and identification of human parainfluenza viruses 1, 2, and 3 from clinical samples by multiplex PCR. J Clin Microbiol 1998; 36:13881391.
  • 22
    Aguilar JC, Perez-Brena MP, Garcia ML, Cruz N, Erdman DD, Echevarria JE. Detection and identification of human parainfluenza viruses 1, 2, 3, and 4 in clinical samples of pediatric patients by multiplex reverse transcription-PCR. J Clin Microbiol 2000; 38:11911195.
  • 23
    Alonso WJ, McCormick BJ. EPIPOI: a user-friendly analytical tool for the extraction and visualization of temporal parameters from epidemiological time series. BMC Public Health 2012; 12:982.
  • 24
    Weinberg GA. Parainfluenza viruses: an underappreciated cause of pediatric respiratory morbidity. Pediatr Infect Dis J 2006; 25:447448.
  • 25
    Hazlett DT, Bell TM, Tukei PM et al. Viral etiology and epidemiology of acute respiratory infections in children in Nairobi, Kenya. The American journal of tropical medicine and hygiene 1988; 39:632640.
  • 26
    Tsai HP, Kuo PH, Liu CC, Wang JR. Respiratory viral infections among pediatric inpatients and outpatients in Taiwan from 1997 to 1999. J Clin Microbiol 2001; 39:111118.
  • 27
    Chew FT, Doraisingham S, Ling AE, Kumarasinghe G, Lee BW. Seasonal trends of viral respiratory tract infections in the tropics. Epidemiol Infect 1998; 121:121128.
  • 28
    Vega-Briceno LE, Pulgar BD, Potin SM, Ferres GM, Sanchez DI. Clinical and epidemiological manifestations of parainfluenza infection in hospitalized children. Rev Chilena Infectol 2007; 24:377383.
  • 29
    Johnson KM, Chanock RM, Cook MK, Huebner RJ. Studies of a new human hemadsorption virus. I. Isolation, properties and characterization. Am J Hyg 1960; 71:8192.
  • 30
    Fairchok MP, Martin ET, Kuypers J, Englund JA. A prospective study of parainfluenza virus type 4 infections in children attending daycare. Pediatr Infect Dis J 2011; 30:714716.
  • 31
    Lau SK, To WK, Tse PW et al. Human parainfluenza virus 4 outbreak and the role of diagnostic tests. J Clin Microbiol 2005; 43:45154521.
  • 32
    Weinberg GA, Erdman DD, Edwards KM et al. Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis 2004; 189:706710.
  • 33
    Minnich LL, Ray CG. Early testing of cell cultures for detection of hemadsorbing viruses. J Clin Microbiol 1987; 25:421422.
  • 34
    Schildgen V, van den Hoogen B, Fouchier R et al. Human Metapneumovirus: lessons learned over the first decade. Clin Microbiol Rev 2011; 24:734754.
  • 35
    Calvo C, Garcia-Garcia ML, Ambrona P et al. The burden of infections by parainfluenza virus in hospitalized children in Spain. Pediatr Infect Dis J 2011; 30:792794.
  • 36
    Oh JW. Respiratory viral infections and early asthma in childhood. Allergol Int 2006; 55:369372.
  • 37
    Porter DD, Prince GA, Hemming VG, Porter HG. Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rats: Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumonia. J Virol 1991; 65:103111.
  • 38
    Fry AM, Curns AT, Harbour K, Hutwagner L, Holman RC, Anderson LJ. Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis 2006; 15:43.
  • 39
    Marx A, Torok TJ, Holman RC, Clarke MJ, Anderson LJ. Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. J Infect Dis 1997; 176:14231427.
  • 40
    Monto AS. Occurrence of respiratory virus: time, place and person. Pediatr Infect Dis J 2004; 23(Suppl 1):S58S64.
  • 41
    Laguna-Torres VA, Gomez J, Aguilar PV et al. Changes in the viral distribution pattern after the appearance of the novel influenza A H1N1 (pH1N1) virus in influenza-like illness patients in Peru. PLoS ONE 2010; 5:e11719.
  • 42
    Kalimuddin S, Sessions OM, Hou Y et al. Successful clearance of human parainfluenza virus type 2 viraemia with intravenous ribavirin and immunoglobulin in a patient with acute myocarditis. J Clin Virol 2013; 56:3740.
  • 43
    Park SY, Baek S, Lee SO et al. Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores. Antimicrob Agents Chemother 2013; 57:983.
  • 44
    Bernstein DI, Malkin E, Abughali N et al. Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children. Pediatr Infect Dis J 2012; 31:109114.